Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.68
Delayed Data
As of Jun 27
 -0.27 / -3.88%
Today’s Change
4.03
Today|||52-Week Range
7.80
+13.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash25.8M74.3M200.3M111.8M
 
 
 
 
 
Short Term Investment Cash41.0M18.6M126.0M-88.5M
 
 
 
 
 
Cash & Short Term Investments55.7M85.8M200.3M111.8M
 
 
 
 
 
 
ReceivablesReceivables--882.0K4.3M5.2M
 
 
 
 
 
InventoriesInventories--7.8M41.9M12.7M
 
 
 
 
 
Current AssetsOther Current Assets1.2M4.1M2.8M3.2M
 
 
 
 
 
Current Assets56.9M98.6M249.3M132.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.2M2.7M5.5M5.5M
 
 
 
 
 
Depreciation-877.0K-1.2M-452.0K-1.2M
 
 
 
 
 
Intangible Assets3.2M3.2M3.2M3.2M
 
 
 
 
 
Other Assets3.5M3.5M4.3M4.3M
 
 
 
 
 
Total Assets60.8M103.6M258.7M141.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable14.0M24.1M21.3M2.2M
 
 
 
 
 
Accrued Expenses------10.8M
 
 
Other Current Liabilities0.00414.0K50.8M11.1M
 
 
 
 
Other Liabilities15.3M29.3M77.6M21.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0090.8M125.0M
 
 
 
Deferred Taxes0.00-700.0K-790.0K-870.0K
 
 
 
 
Other Liabilities38.0K133.0K1.1M1.0M
 
 
 
 
 
Total Liabilities15.4M30.1M171.8M149.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity45.4M73.5M86.9M-8.3M
 
 
 
 
 
Total Shareholder Equity45.4M73.5M86.9M-8.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding82.6M92.7M105.1M105.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.